1-4 of 4
Donald J. Abraham
Close
Sort by
Journal Articles

Various Drugs with or without an Antisickling Effect in the In Vitro Tests Showed a Strong Antisickling Effect in the In Vivo Studies in Transgenic Sickle Mice.

Toshio Asakura, MD, PhD, Osheiza Abdulmalik, DVM, Efe Iyamu, PhD, Qiukan Chen, MD, Jisheng Yang, Donald J. Abraham, PhD, Martin K. Safo, PhD, Carlo Brugnara, MD, Greg Evans, PhD
Journal: Blood
Blood (2005) 106 (11): 3190.
https://doi.org/10.1182/blood.V106.11.3190.3190
Published: 2005
Journal Articles

In Vitro Antisickling Effects of Novel Pyridyl Derivatives with Enhanced Potency.

Osheiza Y. Abdulmalik, DVM, Martin K. Safo, PhD, Gajanan Joshi, PhD, Jisheng Yang, Qiukan Chen, Daniel Obeng, Donald J. Abraham, PhD, Toshio Asakura, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2347.
https://doi.org/10.1182/blood.V106.11.2347.2347
Published: 2005
Journal Articles

MSDD1, a Prodrug of 5-Hydroxymethyl-2-Furfural (5HMF), Prolongs the Antisickling Effect of 5HMF in Transgenic Sickle Mice.

Osheiza Abdulmalik, DVM, Martin K. Safo, PhD, Richmond Danso-Danquah, PhD, Jisheng Yang, Qiukan Chen, MD, Carlo Brugnara, MD, Donald J. Abraham, PhD, Toshio Asakura, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3576.
https://doi.org/10.1182/blood.V104.11.3576.3576
Published: 2004
Journal Articles

Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia

Changqing Wang, Laurent R. Chiarelli, Paola Bianchi, Donald J. Abraham, Alessandro Galizzi, Andrea Mattevi, Alberto Zanella, Giovanna Valentini
Journal: Blood
Blood (2001) 98 (10): 3113–3120.
https://doi.org/10.1182/blood.V98.10.3113
Published: 2001